{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:05:31Z","timestamp":1790975131120,"version":"4.1.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>After the unprecedented success and acceleration of the global agenda towards typhoid fever control with a strong World Health Organization recommendation and the approval of funding from Gavi, the Vaccine Alliance (Gavi), for the use of a new typhoid conjugate vaccine (TCV), we should turn our minds to the challenges that remain ahead. Despite the evidence showing the safety and clinical efficacy of TCV in endemic populations in developing countries, we should remain vigilant and explore hurdles for the full public health impact of TCV, including vaccine supply for the potential global demand, immunization strategies to optimize the effectiveness and long-term protection provided by the vaccines, potential use of TCV in outbreak settings, and scenarios for addressing chronic carriers. Finally, challenges face endemic countries with poor surveillance systems concerning awareness of the need for TCV and the extent of the issue across their populations, and how to target immunization strategies appropriately.<\/jats:p>","DOI":"10.1093\/cid\/ciaa343","type":"journal-article","created":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T12:09:24Z","timestamp":1585310964000},"page":"S185-S190","source":"Crossref","is-referenced-by-count":16,"title":["Typhoid Conjugate Vaccines and Enteric Fever Control: Where to Next?"],"prefix":"10.1093","volume":"71","author":[{"given":"A Duncan","family":"Steele","sequence":"first","affiliation":[{"name":"Enteric and Diarrheal Diseases, Bill & Melinda Gates Foundation, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E","family":"Carey","sequence":"additional","affiliation":[{"name":"Enteric and Diarrheal Diseases, Bill & Melinda Gates Foundation, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya","family":"Kumar","sequence":"additional","affiliation":[{"name":"Enteric and Diarrheal Diseases, Bill & Melinda Gates Foundation, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calman A","family":"MacLennan","sequence":"additional","affiliation":[{"name":"Enteric and Diarrheal Diseases, Bill & Melinda Gates Foundation, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyou-Fu","family":"Ma","sequence":"additional","affiliation":[{"name":"Enteric and Diarrheal Diseases, Bill & Melinda Gates Foundation, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoey","family":"Diaz","sequence":"additional","affiliation":[{"name":"Enteric and Diarrheal Diseases, Bill & Melinda Gates Foundation, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita K M","family":"Zaidi","sequence":"additional","affiliation":[{"name":"Enteric and Diarrheal Diseases, Bill & Melinda Gates Foundation, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"2020073002270666600_CIT0001","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(18)30685-6","article-title":"The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017","volume":"19","author":"Stanaway","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2020073002270666600_CIT0002","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2214-109X(17)30022-0","article-title":"Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study","volume":"5","author":"Marks","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2020073002270666600_CIT0003","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1002\/cam4.915","article-title":"Salmonella enterica serovar Typhi and gallbladder cancer: a case-control study and meta-analysis","volume":"5","author":"Koshiol","year":"2016","journal-title":"Cancer Med"},{"key":"2020073002270666600_CIT0004","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/cid\/cis025","article-title":"A large outbreak of typhoid fever associated with a high rate of intestinal perforation in Kasese District, Uganda, 2008\u20132009","volume":"54","author":"Neil","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2020073002270666600_CIT0005","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/cid\/cis024","article-title":"Typhoid fever and the challenge of nonmalaria febrile illness in sub-Saharan Africa","volume":"54","author":"Crump","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2020073002270666600_CIT0006","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1586\/eri.11.47","article-title":"The utility of diagnostic tests for enteric fever in endemic locations","volume":"9","author":"Parry","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2020073002270666600_CIT0007","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.3389\/fmicb.2017.01794","article-title":"Identification of novel serodiagnostic signatures of typhoid fever using a salmonella proteome array","volume":"8","author":"Darton","year":"2017","journal-title":"Front Microbiol"},{"key":"2020073002270666600_CIT0008","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/cid\/ciy578","article-title":"Plasma immunoglobulin A responses against 2 Salmonella typhi antigens identify patients with typhoid fever","volume":"68","author":"Andrews","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020073002270666600_CIT0009","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1574-6968.1999.tb13382.x","article-title":"Viable, but non-culturable, state of a green fluorescence protein-tagged environmental isolate of Salmonella typhi in groundwater and pond water","volume":"170","author":"Cho","year":"1999","journal-title":"FEMS Microbiol Lett"},{"key":"2020073002270666600_CIT0010","doi-asserted-by":"crossref","first-page":"907170","DOI":"10.1155\/2013\/907170","article-title":"Formation and resuscitation of viable but nonculturable Salmonella typhi","volume":"2013","author":"Zeng","year":"2013","journal-title":"Biomed Res Int"},{"key":"2020073002270666600_CIT0011","author":"Gavi","year":"2019"},{"key":"2020073002270666600_CIT0012","author":"Global Polio Eradication Initiative","year":"2015"},{"key":"2020073002270666600_CIT0013","author":"Global Polio Eradication Initiative","year":"2019"},{"key":"2020073002270666600_CIT0014","author":"Global Polio Eradication Initiative","year":"2018"},{"key":"2020073002270666600_CIT0015","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1186\/s12879-017-2720-2","article-title":"Modifiable risk factors for typhoid intestinal perforations during a large outbreak of typhoid fever, Kampala Uganda, 2015","volume":"17","author":"Bulage","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2020073002270666600_CIT0016","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3748\/wjg.v23.i11.1925","article-title":"Typhoid intestinal perforation in developing countries: still unavoidable deaths?","volume":"23","author":"Contini","year":"2017","journal-title":"World J Gastroenterol"},{"key":"2020073002270666600_CIT0017","author":"Klemm","year":"2018"},{"key":"2020073002270666600_CIT0018","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMp1803926","article-title":"Extensively drug-resistant typhoid\u2014are conjugate vaccines arriving just in time?","volume":"379","author":"Andrews","year":"2018","journal-title":"N Engl J Med"},{"key":"2020073002270666600_CIT0019","first-page":"; 13:e0007868","article-title":"Molecular mechanism of Azithromycin resistance among typhoidal Salmonella strains in Bangladesh identified through passive pediatric surveillance","author":"Hooda","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"2020073002270666600_CIT0020","doi-asserted-by":"crossref","first-page":"110008","DOI":"10.1098\/rsob.110008","article-title":"Combined high-resolution genotyping and geospatial analysis reveals modes of endemic urban typhoid fever transmission","volume":"1","author":"Baker","year":"2011","journal-title":"Open Biol"},{"key":"2020073002270666600_CIT0021","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.12688\/f1000research.20100.1","article-title":"Vaccine impact on antimicrobial resistance to inform Gavi, the Vaccine Alliance\u2019s 2018 Vaccine Investment Strategy: report from an expert survey","volume":"8","author":"Malarski","year":"2019","journal-title":"F1000 Res"},{"key":"2020073002270666600_CIT0022","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/IAI.70.5.2640-2649.2002","article-title":"Biofilm formation and interaction with the surfaces of gallstones by Salmonella spp","volume":"70","author":"Prouty","year":"2002","journal-title":"Infect Immun"},{"key":"2020073002270666600_CIT0023","first-page":"2:8","article-title":"Experimental evolution selects clinically relevant antibiotic resistance in biofilms but with collateral tradeoffs","author":"Trampari","year":"2020;"},{"key":"2020073002270666600_CIT0024","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/cid\/ciy884","article-title":"Overview of the typhoid conjugate vaccine pipeline: current status and future plans","volume":"68","author":"Sahastrabuddhe","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020073002270666600_CIT0025","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1586\/14760584.2013.845529","article-title":"Development of Vi conjugate\u2014a new generation of typhoid vaccine","volume":"12","author":"Szu","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"2020073002270666600_CIT0026","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"2020073002270666600_CIT0027","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2020073002270666600_CIT0028","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"2020073002270666600_CIT0029","article-title":"Safety of typhoid conjugate vaccine","volume":"94:45\u201352","author":"World Health Organization","year":"2019","journal-title":"WHO Wkly Epidemiol Rec"},{"key":"2020073002270666600_CIT0030","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1016\/j.vaccine.2017.08.001","article-title":"The Typhoid Vaccine Acceleration Consortium (TyVAC): vaccine effectiveness study designs: accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26\u201327 October 2016, Oxford, UK","volume":"35","author":"Meiring","year":"2017","journal-title":"Vaccine"},{"key":"2020073002270666600_CIT0031","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1905047","article-title":"Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal","volume":"381","author":"Shakya","year":"2019","journal-title":"N Engl J Med"},{"key":"2020073002270666600_CIT0032","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/cid\/ciy877","article-title":"Ceftriaxone-resistant Salmonella Typhi outbreak in Hyderabad City of Sindh, Pakistan: high time for the introduction of typhoid conjugate vaccine","volume":"68","author":"Yousafzai","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020073002270666600_CIT0033","author":"Luby"},{"key":"2020073002270666600_CIT0034","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1473-3099(13)70241-X","article-title":"Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials","volume":"14","author":"Bhutta","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"2020073002270666600_CIT0035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/nmi2.46","article-title":"Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia","volume":"2","author":"Rahman","year":"2014","journal-title":"New Microbes New Infect"},{"key":"2020073002270666600_CIT0036","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/cid\/ciy927","article-title":"Revised global typhoid vaccination policy","volume":"68","author":"Bentsi-Enchill","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020073002270666600_CIT0037","article-title":"Typhoid vaccine position paper","author":"World Health Organization","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"2020073002270666600_CIT0038","doi-asserted-by":"crossref","first-page":"e0005376","DOI":"10.1371\/journal.pntd.0005376","article-title":"The burden of typhoid fever in low- and middle-income countries: a meta-regression approach","volume":"11","author":"Antill\u00f3n","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2020073002270666600_CIT0039","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1093\/cid\/cit563","article-title":"Trends of etiology and drug resistance in enteric fever in the last two decades in Nepal: a systematic review and meta-analysis","volume":"57","author":"Karki","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2020073002270666600_CIT0040","doi-asserted-by":"crossref","first-page":"e47039","DOI":"10.1371\/journal.pone.0047039","article-title":"O:2-CRM(197) conjugates against Salmonella Paratyphi A","volume":"7","author":"Micoli","year":"2012","journal-title":"PLoS One"},{"key":"2020073002270666600_CIT0041","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clim.2019.03.003","article-title":"Cell mediated immune responses elicited in volunteers following immunization with candidate live oral Salmonella enterica serovar Paratyphi A attenuated vaccine strain CVD 1902","volume":"201","author":"Wahid","year":"2019","journal-title":"Clin Immunol"},{"key":"2020073002270666600_CIT0042","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/cid\/cix042","article-title":"Evaluation of the clinical and microbiological response to Salmonella Paratyphi A infection in the first paratyphoid human challenge model","volume":"64","author":"Dobinson","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2020073002270666600_CIT0043","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/cid\/ciy957","article-title":"Integrating typhoid fever within the sustainable development goals: pragmatism or Utopia?","volume":"68","author":"Bhutta","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020073002270666600_CIT0044","author":"United Nations, Department of Economic and Social Affairs Population Dynamics","year":"2018"},{"key":"2020073002270666600_CIT0045","article-title":"A Quarter of humanity faces looming water crises. The New York Times","author":"Sengupta","year":"2019"},{"key":"2020073002270666600_CIT0046","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S1473-3099(18)30483-3","article-title":"Outbreak investigation of ceftriaxone-resistant Salmonella enterica serotype Typhi and its risk factors among the general population in Hyderabad, Pakistan: a matched case-control study","volume":"18","author":"Qamar","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2020073002270666600_CIT0047","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4269\/ajtmh.18-0428","article-title":"Evaluating PCR-based detection of Salmonella Typhi and Paratyphi A in the environment as an enteric fever surveillance tool","volume":"100","author":"Saha","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"2020073002270666600_CIT0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004346","article-title":"The ecological dynamics of fecal contamination and Salmonella Typhi and Salmonella Paratyphi A in municipal Kathmandu drinking water","volume":"10","author":"Karkey","year":"2016","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/Supplement_2\/S185\/33546388\/ciaa343.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/Supplement_2\/S185\/33546388\/ciaa343.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T06:27:26Z","timestamp":1596090446000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/71\/Supplement_2\/S185\/5877820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":48,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2020,7,29]]},"published-print":{"date-parts":[[2020,7,29]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa343","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8,15]]},"published":{"date-parts":[[2020,7,29]]}}}